Day: October 3, 2026

Ibogaine Treats Parkinson Disease
The search for disease-modifying interventions in neurodegenerative medicine represents one of the most demanding frontiers in modern science. Among chronic motor disorders, Parkinson’s disease stands out as a progressive pathology driven by the selective degeneration of dopaminergic neurons within the substantia nigra, leading to severe tremors, rigidity, bradykinesia, and postural instability. While conventional pharmacological treatments […]
Ibogaine Treats Alzheimer Disease
The search for effective disease-modifying treatments for neurodegenerative conditions remains one of the most pressing challenges in contemporary biomedicine. Among these, Alzheimer’s disease (AD) stands out as a devastating progressive disorder characterized by massive synaptic loss, neuroinflammation, protein aggregation, and the steady deterioration of cognitive faculties. While conventional pharmaceutical approaches largely focus on temporary symptom […]
Ibogaine Treats Panic Anxiety
In contemporary psychiatric research and alternative psychopharmacology, few compounds have generated as much intense scientific inquiry as ibogaine. Derived primarily from the root bark of the West African shrub Tabernanthe iboga, this complex indole alkaloid has historically been studied for its profound effects on interrupting substance use disorders and mitigating severe neurological trauma. However, emerging […]